GHK-Cu: Copper Peptide Research Overview

Overview

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide that binds copper(II) ions with high affinity, forming a stable copper-peptide complex found in human plasma, saliva, and urine. First isolated from human plasma in 1973, GHK-Cu is studied as a signaling molecule that mimics the body’s tissue-damage response — plasma concentrations rise following injury, activating a cascade of repair-related gene expression. Its research profile centers on wound healing, collagen and extracellular matrix synthesis, and — per gene-expression bioinformatics analyses — modulation of a large number of genes associated with tissue remodeling, though the vast majority of this literature is preclinical and in vitro.

Citation: Pickart L., Margolina A., Int J Mol Sci, 2018

History

GHK-Cu was first isolated from the albumin fraction of human plasma in 1973 by biochemist Loren Pickart, who observed that plasma from younger donors caused liver cells from older donors to synthesize proteins more characteristic of younger tissue — an early signal of the peptide’s regenerative signaling properties. Subsequent research through the 1980s and 1990s characterized GHK-Cu as chemotactic for monocytes, macrophages, and mast cells, and demonstrated its ability to accelerate wound closure and support nerve tissue regeneration. More recent research has applied large-scale gene-expression analysis (the Broad Institute’s Connectivity Map) to catalog the peptide’s downstream transcriptional effects across thousands of genes.

Citation: Pickart L., Thaler M.M., 1973

Structure

Research Findings

GHK-Cu has been studied extensively in dermal, connective tissue, and cell-signaling models, with reported activity in wound healing and extracellular matrix biology.

Key Areas of Research

• Dermal/wound healing: Fibroblast recruitment and proliferation, wound closure acceleration, suppression of the acute inflammatory phase response
• Extracellular matrix: Upregulated collagen I/III, elastin, and glycosaminoglycan (dermatan sulfate, chondroitin sulfate, decorin) gene expression via TGF-beta signaling
• Vascular: Angiogenesis promotion, capillary density improvement in damaged tissue
• Gene expression: Broad transcriptional modulation across genes associated with tissue remodeling and antioxidant response, per bioinformatic analyses

Summary: Together, these findings position GHK-Cu as one of the more extensively characterized signaling peptides in regenerative and dermal research, distinguished by its natural occurrence, copper-binding chemistry, and broad transcriptional footprint. Endogenous plasma GHK-Cu concentrations are reported to decline substantially with age, which has driven research interest in its potential role in tissue-repair capacity across the lifespan. As with related compounds in this catalog, findings are drawn primarily from cell culture and animal models.

Citation: Pickart L., Margolina A., Int J Mol Sci, 2018

References

• Pickart L., Thaler M.M. (1973). Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature New Biology.
• Maquart F.X., et al. (1993). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters.
• Pickart L., Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of New Gene Data. International Journal of Molecular Sciences.

Certificate of Analysis

Every lot is independently tested and lot-matched. View Certificates of Analysis

Related Research Categories